Experimental venous thrombosis in rats treated with heparin and a low molecular weight heparin fraction. 1983

C Doutremepuich, and J L Gestreau, and M O Maury, and R Quilichini, and M R Boisseau, and F Toulemonde, and E Vairel

An unfractionated mucosal heparin preparation and a low molecular weight heparin fraction were randomly administered to rats subcutaneously. This injection was made on rats with experimentally induced venous thrombosis. At high doses (6.66 mg/kg) of both drugs, thrombus mean weight was reduced in comparison with a control group. At lower doses (2.22 mg/kg) these two drugs inhibited the growth of the thrombus. This inhibition was obtained with a lower dose (0.66 mg/kg) of the low molecular weight heparin fraction than of heparin. The low molecular weight heparin fraction (molecular weight 5,000 daltons) has a high anti-Xa activity (200 units) and a low activity determined by the USP assay (50 units).

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008297 Male Males
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

C Doutremepuich, and J L Gestreau, and M O Maury, and R Quilichini, and M R Boisseau, and F Toulemonde, and E Vairel
December 1987, Journal of leukocyte biology,
C Doutremepuich, and J L Gestreau, and M O Maury, and R Quilichini, and M R Boisseau, and F Toulemonde, and E Vairel
February 1991, Annals of internal medicine,
C Doutremepuich, and J L Gestreau, and M O Maury, and R Quilichini, and M R Boisseau, and F Toulemonde, and E Vairel
November 1988, JAMA,
C Doutremepuich, and J L Gestreau, and M O Maury, and R Quilichini, and M R Boisseau, and F Toulemonde, and E Vairel
September 1999, The Journal of family practice,
C Doutremepuich, and J L Gestreau, and M O Maury, and R Quilichini, and M R Boisseau, and F Toulemonde, and E Vairel
December 1995, Lancet (London, England),
C Doutremepuich, and J L Gestreau, and M O Maury, and R Quilichini, and M R Boisseau, and F Toulemonde, and E Vairel
September 1991, Medicina clinica,
C Doutremepuich, and J L Gestreau, and M O Maury, and R Quilichini, and M R Boisseau, and F Toulemonde, and E Vairel
July 1986, British journal of haematology,
C Doutremepuich, and J L Gestreau, and M O Maury, and R Quilichini, and M R Boisseau, and F Toulemonde, and E Vairel
December 1999, Managed care (Langhorne, Pa.),
C Doutremepuich, and J L Gestreau, and M O Maury, and R Quilichini, and M R Boisseau, and F Toulemonde, and E Vairel
January 2005, Pathophysiology of haemostasis and thrombosis,
C Doutremepuich, and J L Gestreau, and M O Maury, and R Quilichini, and M R Boisseau, and F Toulemonde, and E Vairel
January 1984, Acta chirurgica Scandinavica,
Copied contents to your clipboard!